Aquestive Therapeutics, Inc. (AQST) Financials

AQST Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 141.1 million 175.2 million
Dec. 31, 2025 160.4 million 194.1 million
Sept. 30, 2025 163.6 million 167.7 million
June 30, 2025 93.7 million 166.3 million

AQST Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -14.9 million 2.3 million
Dec. 31, 2025 -8.6 million 1.4 million
Sept. 30, 2025 -12.9 million 2.8 million
June 30, 2025 -8.0 million 1.9 million

AQST Net Income

No data available :(

AQST Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 110.7 million 114.1 million 4.2 million
Dec. 31, 2025 121.2 million 115.5 million 4.3 million
Sept. 30, 2025 129.1 million 115.9 million 4.5 million
June 30, 2025 60.5 million 31.8 million 5.2 million

AQST Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 122.6 million
Dec. 31, 2025 122.0 million
Sept. 30, 2025 110.6 million
June 30, 2025 99.3 million

AQST Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 52000 4.2 million 11.0 million -
Dec. 31, 2025 85000 3.2 million 32.8 million -
Sept. 30, 2025 235000 4.5 million 15.3 million -
June 30, 2025 107000 4.1 million 12.7 million -

AQST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 14.4 million 3.5 million
Dec. 31, 2025 13.0 million 5.8 million
Sept. 30, 2025 12.8 million 4.5 million
June 30, 2025 10.0 million 4.6 million

AQST Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AQST

Price: $4.15

52 week price:
2.12
7.55

Earnings Per Share: -0.61 USD

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 208846

Market Capitalization: 518.7 million

Links: